SPY002-072 for collagen diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Aug 2025: Trial started, NCT07148414
  2. 29 Aug 2025: Trial registered, NCT07148414

The trials

NCT07148414: A Study of SPY072 in Rheumatic Disease

State
Under way
Phase
Phase 2
People
285 planned
Started
21 Aug 2025
Primary completion
31 Oct 2026
Arms
Rheumatoid Arthritis, Dose Regimen 1, Rheumatoid Arthritis, Dose Regimen 2, Psoriatic Arthritis, Axial Spondyloarthritis
Results
None posted
  1. 21 Aug 2025: Trial started
  2. 29 Aug 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.